Cost-effectiveness analysis of cetuximab/irinotecan vs...

Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment

Starling, N, Tilden, D, White, J, Cunningham, D
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
96
Year:
2007
Language:
english
Pages:
7
DOI:
10.1038/sj.bjc.6603561
File:
PDF, 177 KB
english, 2007
Conversion to is in progress
Conversion to is failed